# Spero Therapeutics, Inc.: Form SC 13D/A, filed Feb 16, 2021

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: SC 13D/A
- Filed: 2021-02-16
- Accepted by EDGAR: Feb 16, 2021, 17:29 ET
- Period: not reported
- Accession: 0001839882-21-002172
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000183988221002172/spro-sc12da_021221.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000183988221002172/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000183988221002172/spro-sc12da_021221.htm

Filed Feb 16, 2021.
Source: SEC EDGAR, the filing index for accession 0001839882-21-002172. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
